The U.S. stock-listed SOL treasury company Sharps Technology generated approximately $17.7 million in revenue in the third quarter through staking income and fair value gains on digital assets.

2025-11-17 12:49:28

According to Deep Tide TechFlow news on November 17, as reported by Globe Newswire, the U.S. medical device sales distribution platform Sharps Technology (STSS) announced its Q3 2025 financial report, showing that its Solana-based financial strategy is performing well.

The company raised a total of $411 million through PIPE financing, of which $267 million is in cash and stablecoins, and $144 million is in SOL tokens. As of October 31, the STSS financial reserve holds over 2 million SOL.

In the third quarter, the company generated approximately $17.7 million in revenue from staking income and the fair value gains of digital assets. As of September 30, the liquidity in cash and stablecoins was approximately $25.2 million.

Chairman Paul K. Danner stated that the adoption of a Solana-based financial strategy combined with successful financing has created the strongest balance sheet in the company's history. The company has completely exited the traditional syringe manufacturing business and is focusing on two strategic priorities: medical device distribution and maximizing the value of its SOL digital asset financial portfolio.

SOL0,87%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.